2m 2m 2m 2m 2m 2m 2m
Lite Strategy (LITS)
NASDAQ
$0.94-$0.04 (-4.48%)
Price as of Nov 12, 2026 9:04 AM EST- $29.4MMarket Cap
- -50.99%1-Year Change
- BiotechnologyIndustry
Lite Strategy (LITS)
$0.94-$0.04 (-4.48%)
LITS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.99 | ||
Change | +$0.03 (+2.86%) | ||
Open | $0.96 | ||
High | $1.02 | ||
Low | $0.93 | ||
Previous Close | $0.96 | ||
Volume | 107,211 | ||
30-Day Average Volume | 257,377 | ||
1-Week Change | -8.79% | ||
1-Month Change | -22.43% | ||
1-Year Change | -50.99% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 29.9M | ||
Total Assets | $58.4M | ||
Market Cap | $29.4M | ||
Enterprise Value | $25.2M | ||
Period: QTR TTM FY | |||
Revenue | $800,000.00 | ||
Net Income | $16.0M | ||
Free Cash Flow | -$2.2M | ||
EBIT | $16.0M | ||
EBITDA | $16.0M | ||
Net Working Capital | $4.5M | ||
EPS | $0.48 | ||
Enterprise Value/EBITDA | 2 | ||
Enterprise Value/Revenue | 31 | ||
P/B | 1 | ||
P/E | 2 | ||
PEG | 0 | ||
Price/Free Cash Flow | -14 | ||
Price/Operating Cash Flow | -14 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue